|
1
|
Suwanwela NC, Phanthumchinda K and
Likitjaroen Y: Thrombolytic therapy in acute ischemic stroke in
Asia: The first prospective evaluation. Clin Neurol Neurosurg.
108:549–552. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nandigam K, Narayan SK, Elangovan S, Dutta
TK, Sethuraman KR and Das AK: Feasibility of acute thrombolytic
therapy for stroke. Neurol India. 51:470–473. 2003.PubMed/NCBI
|
|
3
|
Matsuo R, Kamouchi M, Fukuda H, et al: FSR
Investigators: Intravenous thrombolysis with recombinant tissue
plasminogen activator for ischemic stroke patients over 80 years
old: The Fukuoka Stroke Registry. PLoS One. 9:e1104442014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kumar S, Rajshekher G and Prabhakar S:
Platelet glycoprotein IIb/IIIa inhibitors in acute ischemic stroke.
Neurol India. 56:399–404. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siebler M, Hennerici MG, Schneider D, et
al: Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial.
Stroke. 42:2388–2392. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ciccone A, Abraha I and Santilli I:
Glycoprotein IIb-IIIa inhibitors for acute ischemic stroke. Stroke.
38:1113–1114. 2007. View Article : Google Scholar
|
|
7
|
Haerten K, Krabbe C and Raiber M: Efficacy
and safety of treatment of acute ischemic stroke with glycoprotein
IIb/IIIa receptor blocker in routine clinical practice. Dtsch Med
Wochenschr. 129:607–610. 2004.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bogousslavsky J and Leclerc JR: Platelet
glycoprotein IIb/IIIa antagonists for acute ischemic stroke.
Neurology. 57:(5 Suppl 2). S53–S57. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mazighi M, Meseguer E, Labreuche J and
Amarenco P: Bridging therapy in acute ischemic stroke: A systematic
review and meta-analysis. Stroke. 43:1302–1308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brilakis ES, Banerjee S and Berger PB:
Perioperative management of patients with coronary stents. J Am
Coll Cardiol. 49:2145–2150. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Banks JL and Marotta CA: Outcomes validity
and reliability of the modified Rankin scale: Implications for
stroke clinical trials: A literature review and synthesis. Stroke.
38:1091–1096. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hacke W, Kaste M, Fieschi C, et al:
Randomised double-blind placebo-controlled trial of thrombolytic
therapy with intravenous alteplase in acute ischaemic stroke (ECASS
II). Second European-Australasian Acute Stroke Study Investigators.
Lancet. 352:1245–1251. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pancioli AM, Broderick T, Brott T, et al:
CLEAR Trial Investigators: The combined approach to lysis utilizing
eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke
trial. Stroke. 39:3268–3276. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kleinschnitz C, Pozgajova M, Pham M,
Bendszus M, Nieswandt B and Stoll G: Targeting platelets in acute
experimental stroke: Impact of glycoprotein Ib, VI, and IIb/IIIa
blockade on infarct size, functional outcome, and intracranial
bleeding. Circulation. 115:2323–2330. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Choudhri TF, Hoh BL, Zerwes HG, et al:
Reduced microvascular thrombosis and improved outcome in acute
murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet
aggregation. J Clin Invest. 102:1301–1310. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Moriguchi A, Maeda M, Mihara K, Aoki T,
Matsuoka N and Mutoh S: FK419, a novel nonpeptide GPIIb/IIIa
antagonist, restores microvascular patency and improves outcome in
the guinea-pig middle cerebral artery thrombotic occlusion model:
comparison with tirofiban. J Cereb Blood Flow Metab. 25:75–86.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maeda M, Moriguchi A, Mihara K, et al:
FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist,
ameliorates brain infarction associated with thrombotic focal
cerebral ischemia in monkeys: comparison with tissue plasminogen
activator. J Cereb Blood Flow Metab. 25:108–118. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Coller BS: Binding of abciximab to alpha V
beta 3 and activated alpha M beta 2 receptors: with a review of
platelet-leukocyte interactions. Thromb Haemost. 82:326–336.
1999.PubMed/NCBI
|
|
19
|
Murphy JF, Bourdet JC, Wyler B, et al: The
vitronectin receptor (alpha v beta 3) is implicated, in
coorperation with P-selectin and platelet-activating factor, in the
adhesion of monocytes to activated endothelial cells. Biochem J.
304:537–542. 1994.PubMed/NCBI
|
|
20
|
Molina CA, Alvarez-Sabín J, Montaner J, et
al: Thrombolysis-related hemorrhagic infarction: a marker of early
reperfusion, reduced infarct size, and improved outcome in patients
with proximal middle cerebral artery occlusion. Stroke.
33:1551–1556. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Montaner J, Molina CA, Monasterio J, et
al: Matrix metalloproteinase-9 pretreatment level predicts
intracranial hemorrhagic complications after thrombolysis in human
stroke. Circulation. 107:598–603. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mangiafico S, Cellerini M, Nencini P,
Gensini G and Inzitari D: Intravenous glycoprotein IIb/IIIa
inhibitor (tirofiban) followed by intra-arterial urokinase and
mechanical thrombolysis in stroke. AJNR Am J Neuroradiol.
26:2595–2601. 2005.PubMed/NCBI
|
|
23
|
Junghans U, Seitz RJ, Aulich A, Freund HJ
and Siebler M: Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa
platelet receptor antagonist in progressive stroke: an open pilot
study. Cerebrovasc Dis. 12:308–312. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Platelet Receptor Inhibition in Ischemic
Syndrome Management in Patients Limited by Unstable Signs and
Symptoms (PRISM-PLUS) Study Investigators: Inhibition of the
platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable
angina and non-Q-wave myocardial infarction. N Engl J Med.
338:1488–1497. 1998.PubMed/NCBI
|
|
25
|
Alexandrov AV and Grotta JC: Arterial
reocclusion in stroke patients treated with intravenous tissue
plasminogen activator. Neurology. 59:862–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
